Editor In Chief

Explore 60 Philips statistics covering sales, segments, profitability, employees, research, geographies, restructuring and Respironics-related costs.

ResMed statistics covering revenue, product categories, geography, workforce, digital health and clinical context.

Melatonin statistics covering reported figures, measurement periods and population differences from the available evidence.

A data-based overview of U.S. sleep duration, teen and child routines, insomnia, sleep apnea, and drowsy-driving research.

Sleep health spending statistics covering U.S. healthcare costs, insomnia losses, device-company revenue, remediation and short-sleep context.

Drowsy driving statistics covering U.S. crashes, driver surveys, sleep duration, risk factors, commercial drivers, and international evidence limits.

Sleep and aging statistics covering duration, restfulness, insomnia, sleep apnea, worldwide evidence, and treatment research across older populations.

Sleep and pain statistics covering U.S. prevalence, global associations, sleep disorders, experimental findings and longitudinal risk estimates.

Sleep and heart disease statistics covering duration, apnea, insomnia, cardiovascular outcomes, population differences and major evidence limitations.

Sleep and diabetes statistics covering U.S. prevalence, short sleep, sleep disorders, duration, chronotype, and diabetes-related outcomes.

Sleep and obesity statistics covering U.S. prevalence, age groups, sleep duration, sleep apnea, childhood risk and short-term intervention outcomes.

Sleep and mental health statistics covering U.S. adults, adolescents, insomnia, mental distress, disparities and suicide-risk associations.

Safe infant sleep statistics covering SUID, sleep position, room-sharing, bedding, advice, pacifiers and measured outcomes across U.S. and international studies.

Infant sleep statistics covering duration, routines, safe-sleep practices, bed sharing, feeding patterns, trajectories and measured outcomes.

Adolescent Sleep statistics covering reported figures, measurement periods and population differences from the available evidence.

Sleep hygiene statistics covering bedtime routines, screens, substances, age differences, insomnia trials, costs and perceived sleep sufficiency.

Napping statistics covering prevalence, duration, healthy aging, disease associations, memory, mood, alertness and performance across measured populations.

Jet lag statistics covering travel patterns, sleep disruption, eastward and westward recovery, circadian adaptation, and treatment guidance.

Shift work statistics covering participation, schedules, short sleep, insomnia, sleep disorders, cardiovascular outcomes, safety and schedule interventions.

Circadian Rhythm statistics covering reported figures, measurement periods and population differences from the available evidence.

Sleep clinic statistics covering symptoms, diagnostic pathways, testing definitions, treatment adherence, access and healthcare costs in the United States.

CPAP statistics on adherence, sleepiness, apnea reduction, blood pressure, cardiovascular outcomes, interventions and device-market trends.

Sleep therapy statistics covering CBT-I outcomes, digital treatment, group care, remission, sleep measures and CPAP adherence.

Sleep medication statistics covering U.S. use, age, sex, race, income, sleep duration, drug classes and Medicare trends.

Restless Legs Syndrome statistics covering reported figures, measurement periods and population differences from the available evidence.

Narcolepsy statistics covering reported figures, measurement periods and population differences from the available evidence.

U.S. sleep disorder statistics covering symptoms, insufficient sleep, insomnia, medication use, children, schoolwork, and drowsy driving.

Sleep duration statistics covering U.S. daily sleep, adolescent thresholds, decade trends, mortality, cardiovascular outcomes, and safety behavior associations.

Sleep apnea statistics covering global and U.S. prevalence, severity, pregnancy, children, road safety, costs, PAP adherence and outcomes.

Insomnia statistics covering global prevalence, U.S. symptoms, subgroup patterns, sleep aids, short sleep, daytime sleepiness and persistence.